abstract |
The present invention provides novel 4-methylsulfone substituted piperidinamide compounds for use in the treatment of dilated cardiomyopathy (DCM) and disorders associated with left and/or right ventricular systolic dysfunction or systolic reserve. The present invention describes the synthesis and characterization of compounds, as well as methods for the treatment of DCM and other forms of heart disease. |